Figures & data
Table 1. National Immunization Schedule in 2003 – 2009
Figure 2. Rate (%) of fully immunized children with all routine EPI vaccines in house hold surveys in 2003 and 2009 within 1 y of age (FIC) and by survey's time; I: 95% Confidence interval (CI).
![Figure 2. Rate (%) of fully immunized children with all routine EPI vaccines in house hold surveys in 2003 and 2009 within 1 y of age (FIC) and by survey's time; I: 95% Confidence interval (CI).](/cms/asset/bc1b3c22-903b-4b16-8609-9ddd6f060fc9/khvi_a_1032487_f0002_c.jpg)
Table 2. Population groups for investigation of immunization history
Table 3. Comparison between the reported coverage EPI routine data in 2002 and coverage found by 30 cluster survey in 2003
Figure 3. EPI vaccine coverage rate (%) in Vietnam, 2001 – 2008, based on the routine annual EPI reporting system. TT2 Plus (TT2+) = at least 2 doses of tetanus vaccine.
![Figure 3. EPI vaccine coverage rate (%) in Vietnam, 2001 – 2008, based on the routine annual EPI reporting system. TT2 Plus (TT2+) = at least 2 doses of tetanus vaccine.](/cms/asset/204253c5-d2e4-415c-bb9c-a781232488d5/khvi_a_1032487_f0003_b.gif)
Figure 4. Rate (%) of Protection of infants at birth (PAB) in the 2003 and 2009 surveys. Note: * An infant is considered to be protected at birth against neonatal tetanus if the mother has received 2 doses of tetanus toxoid during the last pregnancy, or at least 3 doses of tetanus toxoid at any time in the past; I: 95% Confidence interval (CI).
![Figure 4. Rate (%) of Protection of infants at birth (PAB) in the 2003 and 2009 surveys. Note: * An infant is considered to be protected at birth against neonatal tetanus if the mother has received 2 doses of tetanus toxoid during the last pregnancy, or at least 3 doses of tetanus toxoid at any time in the past; I: 95% Confidence interval (CI).](/cms/asset/c7e7f76b-e6cb-4cd8-b9bf-82eb78bf0317/khvi_a_1032487_f0004_b.gif)
Figure 5. Coverage rate (%) of Measles dose 2 in surveyed provinces in 2009; I: 95% Confidence interval (CI).
![Figure 5. Coverage rate (%) of Measles dose 2 in surveyed provinces in 2009; I: 95% Confidence interval (CI).](/cms/asset/d1e6643c-e04d-4d55-9895-60e4d09c7c1a/khvi_a_1032487_f0005_b.gif)
Table 4. Comparison between the reported coverage EPI routine data in 2007 and coverage found by 30 cluster surveys